BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 22361769)

  • 21. Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.
    Stolle I; Prenger-Berninghoff E; Stamm I; Scheufen S; Hassdenteufel E; Guenther S; Bethe A; Pfeifer Y; Ewers C
    J Antimicrob Chemother; 2013 Dec; 68(12):2802-8. PubMed ID: 23833179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
    Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
    J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae.
    Potron A; Rondinaud E; Poirel L; Belmonte O; Boyer S; Camiade S; Nordmann P
    Int J Antimicrob Agents; 2013 Apr; 41(4):325-9. PubMed ID: 23305656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
    Hoşoğlu S; Gündes S; Kolayli F; Karadenizli A; Demirdağ K; Günaydin M; Altindis M; Caylan R; Ucmak H
    Indian J Med Microbiol; 2007 Oct; 25(4):346-50. PubMed ID: 18087082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
    Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

  • 28. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals.
    Al-Agamy MH; Aljallal A; Radwan HH; Shibl AM
    J Infect Public Health; 2018; 11(1):64-68. PubMed ID: 28462854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City.
    Landman D; Babu E; Shah N; Kelly P; Bäcker M; Bratu S; Quale J
    J Antimicrob Chemother; 2010 Oct; 65(10):2123-7. PubMed ID: 20667885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Amp C genes encoding for beta-lactamases in Escherichia coli and Klebsiella pneumoniae.
    Shanthi M; Sekar U; Arunagiri K; Sekar B
    Indian J Med Microbiol; 2012; 30(3):290-5. PubMed ID: 22885194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
    Netikul T; Leelaporn A; Leelarasmee A; Kiratisin P
    Int J Antimicrob Agents; 2010 Jun; 35(6):609-10. PubMed ID: 20189774
    [No Abstract]   [Full Text] [Related]  

  • 32. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
    J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbapenem resistance in
    Jaggi N; Chatterjee N; Singh V; Giri SK; Dwivedi P; Panwar R; Sharma AP
    Acta Microbiol Immunol Hung; 2019 Sep; 66(3):367-376. PubMed ID: 31438725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
    Roy S; Datta S; Viswanathan R; Singh AK; Basu S
    J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
    Gupta V; Bansal N; Singla N; Chander J
    J Microbiol Immunol Infect; 2013 Apr; 46(2):104-8. PubMed ID: 22541536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005.
    Wu JJ; Ko WC; Wu HM; Yan JJ
    J Antimicrob Chemother; 2008 Jun; 61(6):1234-9. PubMed ID: 18356152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey].
    Us E; Tekeli A; Arikan Akan O; Dolapci I; Sahin F; Karahan ZC
    Mikrobiyol Bul; 2010 Jan; 44(1):1-10. PubMed ID: 20455393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of Klebsiella pneumoniae ST273 Carrying bla
    Chou A; Roa M; Evangelista MA; Sulit AK; Lagamayo E; Torres BC; Klinzing DC; Daroy ML; Navoa-Ng J; Sucgang R; Zechiedrich L
    Microb Drug Resist; 2016 Oct; 22(7):585-588. PubMed ID: 27032000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India.
    Ansari MA; Khan HM; Khan AA; Sultan A; Azam A
    Appl Microbiol Biotechnol; 2012 Apr; 94(2):467-77. PubMed ID: 22159886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Enterobacteriaceae producing CTX-M extended spectrum beta-lactamases from a tertiary care hospital in south India.
    Baby Padmini S; Appala Raju B; Mani KR
    Indian J Med Microbiol; 2008; 26(2):163-6. PubMed ID: 18445956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.